SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sigachi Industries - Quaterly Results

18 Jan 2025 Evaluate
A decent increase of about 36.76% in the sales to Rs. 1050.76 millions was observed for the quarter ended December 2024. The sales figure stood at Rs. 768.33 millions during the year-ago period.The Net Profit of the company registered a slight decline of -10.17% to Rs. 96.77  millions from Rs. 107.72 millions.Operating profit for the quarter ended December 2024 rose to 232.36 millions as compared to 174.96 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1050.76 768.33 36.76 2942.93 2338.44 25.85 3175.00 2903.24 9.36
Other Income 20.46 16.84 21.50 183.05 44.08 315.27 115.73 66.72 73.46
PBIDT 232.36 174.96 32.81 738.72 487.29 51.60 708.66 624.85 13.41
Interest 33.57 16.72 100.78 78.56 45.94 71.01 70.20 42.87 63.75
PBDT 198.79 158.24 25.63 660.16 441.35 49.58 638.46 581.98 9.70
Depreciation 39.58 20.62 91.95 89.81 59.86 50.03 87.09 66.21 31.54
PBT 159.21 137.62 15.69 570.35 381.49 49.51 551.37 515.77 6.90
TAX 62.44 29.90 108.83 163.47 88.63 84.44 141.23 100.18 40.98
Deferred Tax 32.13 3.42 839.47 71.89 15.48 364.41 32.08 -2.06 -1657.28
PAT 96.77 107.72 -10.17 406.88 292.86 38.93 410.14 415.59 -1.31
Equity 333.44 323.48 3.08 333.45 323.48 3.08 328.20 307.43 6.76
PBIDTM(%) 22.11 22.77 -2.89 25.10 20.84 20.46 22.32 21.52 3.71

Sigachi Industries Share Price

23.35 0.04 (0.17%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×